Article
CAR T Cell Therapy: A Versatile Living Drug
27 Mar 2023
Abstract excerpt
After seeing a dramatic increase in the development and use of immunotherapy and precision medicine over the past few decades, oncological care now embraces the start of the adoptive cell therapy (ACT) era. This impulse towards a new treatment paradigm has been led by chimeric antigen receptor (CAR) T cells, the only type of ACT medicinal product to be commercialized so far. Brought about by an ever-growing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
